pasireotide
Per policy, these hazardous drugs have special waste requirements. | |
---|---|
Generic (Brand) | Waste Requirements |
pasireotide (Signifor) | Hazardous Waste ⇒ BLACK BUCKET |
USP <800> Hazardous Drugs | ||||||
---|---|---|---|---|---|---|
Per Policy, these drugs have special handling requirements (any drug with an "AOR" is exempt from these requirements under normal circumstances). | ||||||
generic (Brand) Route | Relative Risk Level | AOR? | NIOSH 2024 Table | MSHI?↑ | Warnings | |
pasireotide (Signifor) SQ/IM | Low | N/A | 2B↑ | |||
NIOSH Supplemental information (2016): Increased implantation loss and decreased viable fetuses, corpora lutea, and implantation sites at doses less than the human recommended dose FDA Pregancy Category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks; |